Mannkind (MNKD) Change in Accured Expenses (2010 - 2026)
Mannkind (MNKD) reported Change in Accured Expenses of -$5.8 million for Q1 2026, down 4406.72% year-over-year from $134000.0 in Q1 2025, and down 143.23% on a QoQ basis from $13.4 million in Q4 2025.
Mannkind (MNKD) has 17 years of Change in Accured Expenses data on file, last reported at -$5.8 million in Q1 2026.
- Quarterly Change in Accured Expenses fell 4406.72% year-over-year to -$5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.6 million (up 18.22% YoY) and the FY2025 annual result came in at $3.3 million, up 220.46% from the prior year.
- Change in Accured Expenses retreated to -$5.8 million in Q1 2026 per MNKD's latest filing, from $13.4 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $13.4 million in Q4 2025 and bottomed at -$9.5 million in Q2 2025.
- The 5-year median for Change in Accured Expenses is -$644000.0 (2022), against an average of $39117.6.
- The widest annual swing landed in 2023, when Change in Accured Expenses surged 769.45%; it then tumbled 4406.72% in 2026.
- Tracing MNKD's Change in Accured Expenses over 5 years: stood at -$1.6 million in 2022, then surged by 769.45% to $10.4 million in 2023, then tumbled by 79.81% to $2.1 million in 2024, then soared by 533.9% to $13.4 million in 2025, then slumped by 143.23% to -$5.8 million in 2026.
- Per Business Quant, the three latest MNKD Change in Accured Expenses figures stand at -$5.8 million (Q1 2026), $13.4 million (Q4 2025), and -$761000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -5.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.77 Mn |
| Mar 31, 2026 | -5.77 Mn |
| Dec 31, 2025 | 13.35 Mn |
| Dec 31, 2025 | 13.35 Mn |
| Sep 30, 2025 | -761,000.00 |
| Sep 30, 2025 | -761,000.00 |
| Jun 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Mar 31, 2025 | 134,000.00 |
| Mar 31, 2025 | 134,000.00 |
| Dec 31, 2024 | 2.11 Mn |
| Dec 31, 2024 | 2.11 Mn |
| Sep 30, 2024 | -3.05 Mn |
| Sep 30, 2024 | -3.05 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Jun 30, 2024 | -2.43 Mn |
| Mar 31, 2024 | 670,000.00 |
| Mar 31, 2024 | 670,000.00 |
| Dec 31, 2023 | 10.43 Mn |
| Dec 31, 2023 | 10.43 Mn |
| Sep 30, 2023 | -4.18 Mn |
| Sep 30, 2023 | -4.18 Mn |
| Jun 30, 2023 | 3.91 Mn |
| Jun 30, 2023 | 3.91 Mn |
| Mar 31, 2023 | -3.56 Mn |
| Mar 31, 2023 | -3.56 Mn |
| Dec 31, 2022 | -1.56 Mn |
| Dec 31, 2022 | -1.56 Mn |
| Sep 30, 2022 | 969,000.00 |
| Sep 30, 2022 | 969,000.00 |
| Jun 30, 2022 | -644,000.00 |
| Jun 30, 2022 | -644,000.00 |
| Mar 31, 2022 | 510,000.00 |
| Mar 31, 2022 | 510,000.00 |
| Dec 31, 2021 | 5.34 Mn |
| Dec 31, 2021 | 5.34 Mn |
| Sep 30, 2021 | 256,000.00 |
| Sep 30, 2021 | 256,000.00 |
| Jun 30, 2021 | -5.07 Mn |
| Jun 30, 2021 | -5.07 Mn |
| Mar 31, 2021 | 8.29 Mn |
| Mar 31, 2021 | 8.29 Mn |
| Dec 31, 2020 | 2.71 Mn |
| Dec 31, 2020 | 2.71 Mn |
| Sep 30, 2020 | 1.98 Mn |
| Sep 30, 2020 | 1.98 Mn |
| Jun 30, 2020 | -3.22 Mn |
| Jun 30, 2020 | -3.22 Mn |
| Mar 31, 2020 | 1.88 Mn |
| Mar 31, 2020 | 1.88 Mn |
| Dec 31, 2019 | 2.96 Mn |
| Dec 31, 2019 | 2.96 Mn |
| Sep 30, 2019 | -594,000.00 |
| Sep 30, 2019 | -594,000.00 |
| Jun 30, 2019 | -1.88 Mn |
| Jun 30, 2019 | -1.88 Mn |
| Mar 31, 2019 | 2.34 Mn |
| Mar 31, 2019 | 2.34 Mn |
| Dec 31, 2018 | 1.69 Mn |
| Dec 31, 2018 | 1.69 Mn |
| Sep 30, 2018 | -258,000.00 |
| Sep 30, 2018 | -258,000.00 |
| Jun 30, 2018 | -1.86 Mn |
| Jun 30, 2018 | -1.86 Mn |
| Mar 31, 2018 | 2.68 Mn |
| Mar 31, 2018 | 2.68 Mn |
| Dec 31, 2017 | 43,000.00 |
| Dec 31, 2017 | 43,000.00 |
| Sep 30, 2017 | 3.37 Mn |
| Sep 30, 2017 | 3.37 Mn |
| Jun 30, 2017 | -1.56 Mn |
| Jun 30, 2017 | -1.56 Mn |
| Mar 31, 2017 | 1.08 Mn |
| Mar 31, 2017 | 1.08 Mn |
| Dec 31, 2016 | -6.23 Mn |
| Dec 31, 2016 | -6.23 Mn |
| Sep 30, 2016 | 3.91 Mn |
| Sep 30, 2016 | 3.91 Mn |
| Jun 30, 2016 | 2.18 Mn |
| Jun 30, 2016 | 2.18 Mn |
| Mar 31, 2016 | 488,000.00 |
| Mar 31, 2016 | 488,000.00 |
| Dec 31, 2015 | -6.55 Mn |
| Dec 31, 2015 | -6.55 Mn |
| Sep 30, 2015 | 1.88 Mn |
| Sep 30, 2015 | 1.88 Mn |
| Jun 30, 2015 | -8.51 Mn |
| Jun 30, 2015 | -8.51 Mn |
| Mar 31, 2015 | 710,000.00 |
| Mar 31, 2015 | 710,000.00 |
| Dec 31, 2014 | 90,000.00 |
| Dec 31, 2014 | 90,000.00 |
| Sep 30, 2014 | 5.50 Mn |
| Sep 30, 2014 | 5.50 Mn |
| Jun 30, 2014 | -4.03 Mn |
| Jun 30, 2014 | -4.03 Mn |
| Mar 31, 2014 | 714,000.00 |
| Mar 31, 2014 | 714,000.00 |
| Dec 31, 2013 | -2.93 Mn |
| Dec 31, 2013 | -2.93 Mn |
| Sep 30, 2013 | 1.13 Mn |
| Sep 30, 2013 | 1.13 Mn |
| Jun 30, 2013 | 1.68 Mn |
| Jun 30, 2013 | 1.68 Mn |
| Mar 31, 2013 | 715,000.00 |
| Mar 31, 2013 | 715,000.00 |
| Dec 31, 2012 | -21.82 Mn |
| Dec 31, 2012 | -21.82 Mn |
| Sep 30, 2012 | 3.59 Mn |
| Sep 30, 2012 | 3.59 Mn |
| Jun 30, 2012 | 31.42 Mn |
| Jun 30, 2012 | 31.42 Mn |
| Mar 31, 2012 | 1.89 Mn |
| Mar 31, 2012 | 1.89 Mn |
| Dec 31, 2011 | 5.18 Mn |
| Dec 31, 2011 | 5.18 Mn |
| Sep 30, 2011 | -3.71 Mn |
| Sep 30, 2011 | -3.71 Mn |
| Jun 30, 2011 | 724,000.00 |
| Jun 30, 2011 | 724,000.00 |
| Mar 31, 2011 | 3.85 Mn |
| Mar 31, 2011 | 3.85 Mn |
| Dec 31, 2010 | -3.46 Mn |
| Dec 31, 2010 | -3.46 Mn |
| Sep 30, 2010 | -783,000.00 |
| Sep 30, 2010 | -783,000.00 |